Yahoo! Finance: Biotechnology Industry News: Sobi gains rights to distribute RAVICTI(R) on a named patient use basis in Middle East from Hyperion Therapeutics, Inc.

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

TypePad Has the Tools Looking for a premiere blogging service? Start your blog today on TypePad. From our sponsors

Sobi gains rights to distribute RAVICTI(R) on a named patient use basis in Middle East from Hyperion Therapeutics, Inc. Oct 1st 2013, 06:06 [GlobeNewswire] - STOCKHOLM, Sweden and SOUTH SAN FRANCISCO, Calif. --

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions